You are here

Intake and distribution of doxycycline in the organism of broiler chickens

The article presents the results of studies on the absorption, distribution and excretion of the antibiotic Poledoxin (the active substance is doxycycline hyclact) from the body of healthy broiler chickens of the Koob-500 cross when taken orally. Studies have established the rapid absorption of doxycycline hyclact from the digestive tract of the chicken into the blood and its entry into the internal organs. The maximum concentration of doxycycline hyclact was detected 2-4 hours after the start of Poledoxin administration, the content of which in the liver was 9,07±0,07 μg/g, in the lungs – 8,39±0,20 μg/g, in the heart – 4,24±0,09 μg/g, in the pectoral muscles – 4,28±0,23 μg/g. In the kidneys, the maximum concentration was found after 12 hours – 7,63±0,38 μg/g. When clinically healthy broiler chickens were fed with Poledoxin solution, the ability to materially cumulate doxycycline hyclact (active ingredient) was not established, since its content in the internal organs and muscles of the bird did not depend on the duration of the drug use. Studies have established the absence of organ affiliation of doxycycline hyclact, because its maximum content, depending on the study period, was recorded in various organs that provide biotransformation and excretion – liver, kidneys, lungs. The cancellation of drinking Poledoxin ensured the rapid elimination of doxycyclin hyclact from the body of broiler chickens and, after 5 days (for 216 hours of the experiment), its content was minimal for the entire study period and amounted to: in the kidneys – 0,15±0,01 μg/g; liver – 0,12±0,01 μg/g; pectoral muscles – 0,05±0,01 μg/g; lungs – 0,04±0,01 μg/g. Only in one sample of the heart, doxycycline hyclact was shown in an amount of 0,01 μg/g. Key words: Poledoxin, doxycycline hyclact, broiler chickens, distribution, accumulation, hatching, bioavailability, pharmacokinetics, excretion.

  1. Fairchild, A. S., Smith, J. L., Idris, U. (2005). Effects of Orally Administered Tetracycline on the In-testinal Community Structure of Chickens and on tet Determinant Carriage by Commensal Bacteria and Campylobacter jejuni. Applied and environmental microbiology. no. 71(10), pp. 5865–5872. Available at:https://doi.org/10.1128/ AEM.71.10.5865-5872.2005.
  2. Sanders, P., Henri, J., Laurentie, M. (2016). Tools to evaluate pharmacokinetics data for establish-ing maximum residue limits for approved veterinary drugs: examples from JECFA’s work. Drug Testing and Analysis. no. 8, pp. 565– 571. Available at:https://doi.org/10.1002/dta.2006.
  3. Yang, F., Wang, G., Kong, T. (2018). Pharmacokinetics of doxycycline after oral administration of single and multiple dose in broiler chickens. Veterinary pharmacology and Therapeutics. no. 41(6), pp. 919–923. Available at:https://doi. org/10.1111/jvp.12699.
  4. Agwuh, K.N., MacGowan, A. (2006). Pharmacokinetics and pharmacodynamics of the tetra-cy- clines including glycylcyclines. Journal of An-timicrobial Chemotherapy. no. 58(2), pp. 256–265. Available at:https:// doi.org/10.1093/jac/dkl224.
  5. Hsiao, P.F., Chang, S.K., Hsu, T.H. (2016). Pharmacokinetics and tissue depletion of doxycycline administered at high dosage to broiler chickens via the drinking water. Acta Veterinaria Hungarica. no. 64(4), pp. 472–481. Available at:https://doi.org/10.1556/004.2016.044.
  6. Gbylik‐Sikorska, M., Gajda, A., Posyniak, A. (2017). Pharmacokinetic depletion phase of doxycycline in healthy and Mycoplasma gallisepticum‐infected chicken broilers after coad-ministration of enrofloxacin traces. Journal of veterinary pharmacology and therapeutics. no. 41(1), pp. 166–169. Available at:https://doi.org/10.1111/jvp.12433.
  7. Elkomy, A. A., Eltanany, N., Aboubakr, M. (2018). Pharmacokinetics and tissue residues of Tilmicosin in normal and experimentally ycoplasma Gallisepticum-infected broiler chickens. Benha Veterinary Medical Journal. no. 34(3), pp.188–205.
  8. Latif, A., El-Hanbally, S. (2018). Disposition kinetics, in vitro plasma protein binding and tis-sue residues of tilmicosin in healthy and experimentally (CRD) infected broiler chickens. International Journal of Basic & Clinical Pharmacology. no. 7(11), pp. 2201–2208.
  9. Ambrose, P.G., Bhavnani, S.M., Ru-bino, C.M., Louie, A., Gumbo, T., Forrest, A., Drusano, G.L. (2007). Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore. Clinical Infection Diseases Journal. no. 44, pp. 79–86.
  10. Bhattaram, V. A., C. Bonapace, D. M. (2007). Impact of pharmacometric reviews on new drug approval and labeling decisions – a survey of 31 new drug applications sub-mitted between 2005 and 2006. Clinical Pharmacology and Therapeutics. no. 81(2), pp. 213–222.
  11. Nielsen, E.I., Cars, O., Friberg, L.E. (2011). Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PK/PD model: a step toward mod-elbased dose optimization. Antimicrobial Agents and Chemotherapy. no. 55(10), pp. 4619–4630.
  12. Reeves, P.T., Cunningham, F.M., Lees, P., Elliott, J. (2010). Drug residues. in Handbook of Experimental Pharma-cology. Comparative and Veterinary Pharmacology. pp. 265–290.
  13. Borghi, A. A., Palma, M. S. (2014). Tetracycline: production, waste treatment and envi-ronmental impact assessmen. Brazilian Journal of Pharmaceutical Sciences. no. 50(1), pp. 25–40. Available at:https://doi.org/10.1590/ S1984-82502011000100003
  14. Abu-Basha, E. A., Al-Shunnaq, A.F., Gehring, R. (2012). Comparative Pharmacokinetics and Bioavailability of Two Tylosin Formulations in Chickens after Oral Administration. Journal of the Hellenic Veterinary Medical Society. no. 63, pp. 159–165.
  15. Mestorino, N., Zeinsteger, I. P., Buchamer, I. A. (2018). Tissue depletion of doxycycline after its oral administration in food producing chicken for fattening. International Journal of Avian & Wildlife Biology. no. 3(3), pp. 252–257.
  16. Anadón, A., Gam-boa, F., Aránzazu Martínez, M. (2012). Plasma disposition and tissue depletion of chlortetracycline in the food producing animals, chickens for fattening. Food Chemical Toxicology. no. 50(8), pp. 2714–2721.
  17. Peeters, L., Croubels, S., Rasschaert, G. (2018). Effect of residual doxycycline concentrations on resistance selection and transfer in porcine commensal Escherichia coli. International Journal Antimicrobial Agents. no. 51(1), pp.123–127.
  18. El–Gendi, A.Y., Atef, M., Amer, A.M. (2010). Pharmacokinetic tissue distribution of doxycycline in broiler chickens pretreated with either: diclazuril or halofuginon. Food Chemical Toxicology. no. 48(11), pp. 3209–3214.
  19. Gajda, A., Posyniak, A., Tomczyk, G. (2014). LC– MS/MS analysis of doxycycline residues in chicken tis-sues after oral administration. Bulletin – Veterinary Institute in Pulawy. no. 58(4), pp. 573–579.
  20. Vandenberge, V., Delezie, E., Huyghebaert, G. (2012). Residues of sulfadiazine and doxycycline in broiler liver and muscle tissue due to cross contamination of feed. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment. no. 29 (2), pp. 180–188.
AttachmentSize
PDF icon tyshkivskaya_2_2020.pdf514.89 KB